There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

Percutaneous treatment of hepatocellular carcinoma (HCC) encompasses a vast range of
techniques, including monopolar radiofrequency ablation (RFA), multibipolar RFA …

Image‐guided percutaneous ablation is considered best in the treatment of early‐stage
hepatocellular carcinoma (HCC). Ablation is potentially curative, minimally invasive, and …

Hepatocellular carcinoma (HCC), in its very early stage, is heterogeneous both in terms of
liver function (ie, presence or absence of portal hypertension, model for end-stage liver …

Hepatocellular carcinoma (HCC) is an increasing health problem, representing the second
cause of cancer-related mortality worldwide. The major risk factor for HCC is cirrhosis. In …

Primary and metastatic liver tumors are an increasing global health problem, with
hepatocellular carcinoma (HCC) now being the third leading cause of cancer-related …

Background The effects of direct-acting antivirals (DAAs) on survival and recurrence rates
after curative hepatocellular carcinoma (HCC) treatment in patients with hepatitis C virus …

Background Liver resection is the first-line treatment for patients with resectable colorectal
liver metastasis (CRLM), while radiofrequency ablation (RFA) can be used for small …

Radiofrequency ablation (RFA) has gained a wide acceptance as a first-line therapeutic
option for small hepatocellular carcinoma (HCC). For very early-stage HCC, despite a higher …

AIM: To compare outcomes from radiofrequency ablation (RFA) and hepatectomy for
treatment of colorectal liver metastasis (CRLM). METHODS: From January 2000 to …